Inovio Pharmaceuticals
INO
#9646
Rank
NZ$0.19 B
Marketcap
NZ$1.85
Share price
21.10%
Change (1 day)
-32.37%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): NZ-$3.89

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$3.85. In 2025 the company made an earnings per share (EPS) of NZ-$3.07 an increase over its 2024 EPS that were of NZ-$6.70.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.8926.61%
2025NZ-$3.07-54.18%
2024NZ-$6.70-35.14%
2023NZ-$10.33-56.62%
2022NZ-$23.82-19.54%
2021NZ-$29.6135.9%
2020NZ-$21.79-11.57%
2019NZ-$24.6415.24%
2018NZ-$21.38-2.78%
2017NZ-$21.996.93%
2016NZ-$20.56134.88%
2015NZ-$8.75-29.51%
2014NZ-$12.42-57.34%
2013NZ-$29.12146.55%
2012NZ-$11.8120.83%
2011NZ-$9.77-29.41%
2010NZ-$13.85-48.48%
2009NZ-$26.8810%
2008NZ-$24.4311.11%
2007NZ-$21.99-41.3%
2006NZ-$37.46-66.91%
2005NZ-$113.20110.61%
2004NZ-$53.75-61.63%
2003NZ-$140.08186.67%
2002NZ-$48.86
2001N/A-100%
2000NZ-$39.09-63.64%
1999NZ-$107.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.82-484.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.91-409.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.22-157.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$12.59-426.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.07-257.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.59-271.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ$1.37-135.68%๐Ÿ‡บ๐Ÿ‡ธ USA